Aims The proliferative potential of pluripotent stem cell-derived cardiomyocytes is limited, and reasonable yields for novel therapeutic options have yet to be achieved. In addition, various clinical applications will require the generation of specific cardiac cell types. Whereas early cardiovascular precursors appear to be important for novel approaches such as reseeding decellularized hearts, direct cell transplantation may require ventricular cells. Our recent work demonstrated that MesP1 represents a master regulator sufficient to induce cardiovasculogenesis in pluripotent cells. This led to our hypothesis that 'forward programming' towards specific subtypes may be feasible via overexpression of distinct early cardiovascular transcription factors.
Introduction
Current therapeutic modalities for degenerative cardiovascular diseases are limited. They include medical therapy, mechanical left ventricular assist devices, and cardiac transplantation. Embryonic stem (ES) cells or pluripotent stem cells from recently described novel sources, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] which can differentiate into functional cardiovascular cells, may enable cardiovascular cell transplantation. 12, 13 However, the proliferative potential of stem cell-derived cardiomyocytes is limited and reasonable yields to repair a human infarcted heart (. 10 10 cardiomyocytes) have yet to be achieved.
14 Therefore, it is crucial to decipher the underlying biological processes in order to pre-program pluripotent stem cells towards a cardiovascular fate for cell therapy and cardiovascular tissue engineering. This knowledge may even provide a tool to elicit cardiac transdifferentiation in native human adult stem cells. In a first attempt of such 'cardiovascular forward programming' using pluripotent stem cells, we have recently shown that MesP1 is a key factor sufficient to induce cardiovasculogenesis. 15 In ES cells, MesP1 overexpression resulted in significantly increased numbers of beating cardiomyocytes and of endothelial cells. Our experiments revealed a prominent function of MesP1 within a gene regulatory cascade causing Dkk-1 mediated blockage of canonical Wnt-signalling. We thereby defined the Dkk-1 promoter as a direct target, activated by MesP1 protein. We have also demonstrated that MesP1-induced ES cell based cardiomyogenesis requires the initial presence of general mesoderm inducing factors evident from fluorescent activated cell sorting (FACS) analyses for Flk-1 (VEGFR-2, KDR), the earliest surface marker for the lateral mesoderm, 16 which was not increased until day 4-6 of differentiation, when lateral and paraxial mesoderm have formed. 15, 17 Electrophysiological analysis of isolated beating cardiomyocytes showed all subtypes of cardiac ES cell differentiation albeit with a high proportion of yet uncommitted early/intermediate cell types. 18, 19 Whereas these earliest cardiovascular precursors may become important for innovative approaches such as reseeding whole decellularized hearts 20 in order to reconstitute the whole myocardium including the vasculature, direct cell transplantation may rather be dependent on specific ventricular cells, e.g. to repair a typical infarction. Therefore, in long term, the specific generation of cardiovascular cellular subtypes has to be taken into account for various clinical applications or to transfer specific diseases to in vitro models.
As a candidate for directed ventricular differentiation of stem cells, we now have chosen Nkx2.5/Csx because of its known importance for the underlying processes in the embryo, where this factor plays an important role in specification and maturation of ventricular cardiomyocytes. 21 As a member of the NK homeobox gene family Nkx2.5/Csx is conserved in evolution and acts as a DNA-binding transcriptional activator. 22, 23 The high evolutionary conservation is underlined by the fact that Nkx2.5/Csx homologues have been identified in various vertebrate species from Xenopus to humans [24] [25] [26] [27] [28] as well as in non-vertebrates: in Drosophila, tinman, the homologue of Nkx2.5/Csx in the fly is required for cell fate specification of the dorsal vessel, the equivalent of the vertebrate heart. 29, 30 In vertebrates, Nkx2.5/Csx plays an important role in lineage specification and maturation of ventricular cardiomyocytes as shown via ventricular restricted Nkx2.5/Csx knockout mice. Thereby cell type specific loss of Nkx2.5/Csx was achieved by MLC2v-Cre-mediated recombination 21 of the floxed Nkx2.5/Csx allele. The importance of Nkx2.5/Csx in ventricular formation is further underlined by the fact that expression of the ventricular-specific homeobox gene Irx4 requires correct Nkx2.5/Csx and dHAND expression. 31 Correspondingly, complete loss of Nkx2.5/Csx during embryogenesis leads to formation of only a single atrial chamber with complete ventricular dysgenesis. 31 On the basis of this background, we compared the effect of forced expression of Nkx2.5/Csx with that of the cardiovascular fate inducer MesP1 on ES cell development. We hypothesized that overexpression of Nkx2.5/Csx specifically may enhance the yield of ventricular cells, whereas MesP1 may rather promote the earliest yet multipotent cardiovascular precursors. Our data show proof of principle for such cardiovascular subtype-specific programming of stem cells and confirm the molecular hierarchy for cardiovascular specification initiated via MesP1 with the key factor Nkx2.5 further downstream.
Methods

Plasmid construction and ES cell culture
The human Nkx2.5 cDNA was cloned into pIRES-EGFP-2 and used for the generation of stably overexpressing ES cell clones as described. 15 For details please refer to Supplementary material online.
Western blotting
A polyclonal antibody specific for human Nkx2.5/Csx obtained from R&D systems was used for western blotting according to standard protocols. 15 
Flow cytometry
FACS analyses were performed as described. 15 For details please refer to Supplementary material online.
Confocal analyses
Immunostaining was performed according to standard protocols as described. 15 For details please refer to Supplementary material online.
Electrophysiological analyses
Isolation and electrophysiological analysis of spontaneously beating cardiac cells from embryoid bodies (EBs) was done as described. 15 For details please refer to Supplementary material online.
Real-time PCR
Quantitative real-time PCR was performed as described. 15 For details please refer to Supplementary material online.
Results
Generation of stably Nkx2.5 and Mesp1 overexpressing ES cell lines
Relying on the high conservation of vertebrate Nkx2.5 proteins, we used the human Nkx2.5 in murine ES cells due to the specific traceability. We inserted the human Nkx2.5 cDNA in pIRES-EGFP-2 (Clontech) for overexpression in ES cells (Supplementary material online, Figure S1A ) simultaneously allowing visualization of ES cell clones via EGFP ( Figure 1A and B). Nkx2.5 overexpression was confirmed on the protein level (Supplementary material online, Figure S1B ). The generation of MesP1 overexpressing ES cell lines has been described in detail. 15 As expected qRTPCRs showed no significant influence of Nkx2.5 overexpression on Oct4, Nanog and Rex-1 mRNA levels compared with control transfected cells. This corresponds with normal undifferentiated colony growth in leukemia inhibitory factor (LIF) containing medium ( Figure 1A and B) and is in agreement with our previous findings for MesP1 overexpression. 15 We concluded that similar to MesP1 likewise Nkx2.5 alone is not sufficient to induce cardiac differentiation of ES cells. However, in FACS analyses for Flk-1 (VEGFR-2, KDR), the earliest surface marker for the lateral plate mesoderm, 16 we did not observe a shift of nascent mesoderm towards a cardiovascular fate. This is reflected in unaltered numbers of Flk-1 expressing cells after Nkx2.5 overexpression as opposed to MesP1 (Figure 2 ).
Effect of Nkx2.5 and Mesp1 overexpression on the yield of spontaneously beating ES cell-derived cardiomyocytes
We next performed qRT-PCRs for known target genes of Nkx2.5 at day 10 of differentiation. These revealed a ninefold increase of mRNA encoding Mef2c and a 6.7-fold increase of ANF mRNA in three independent pooled clones ( Figure 3) confirming the functionality of the overexpressed transcription factor in our ES cell clones. Again, our established hMesP1 and EGFP transfected clones 15 served as positive and negative controls. As a marker for the second vs. the primary heart fields, we analysed the mRNA levels for Isl1 and Tbx20 32, 33 and Tbx5, 34 respectively. These were significantly increased in Nkx2.5 as well as MesP1 clones, whereas Tbx2 mRNA, a marker for blockage of chamber differentiation, 35, 36 was reduced in Nkx2.5 as opposed to MesP1 clones ( Figure 3) . As epicardial markers, we analysed Tbx18 and Wt1 37,38 mRNAs both of which were increased in Nkx2.5 and MesP1 clones ( Figure 3) .
During differentiation Nkx2.5 overexpressing ES cell clones started to contract earlier and showed four-to six-fold more contracting areas (Supplementary material online, Figure S2 and Movies 1 and 2). This enhanced cardiac differentiation resembles the effect of MesP1 overexpression recently described by us, 15 however the MesP1 programmed cells appeared to maintain their maximal beating activity slightly more robust (Supplementary material online, Figure S2 ). In correspondence with their beating activity, Nkx2.5 overexpressing cardiomyocytes showed normal patterns of the sarcomeric markers a-Actinin and TroponinI ( Figure 4A and B) and Connexin43 expression revealed intercellular contacts ( Figure 4C ).
Effect of Nkx2.5 and Mesp1 overexpression on the number of cardiovascular marker expressing cells
We next investigated whether our observations are reflected by protein expression patterns and found two-fold increased numbers of cells expressing a-Actinin, which is expressed in cardiomyocytes as well as skeletal myocytes ( Figure 5A ). However, the numbers of cells expressing the cardiac specific structural markers TnI and cardiac MLC-1 ( Figure 5B and C) were four-fold increased, indicating that the specific induction of cardiogenesis in Nkx2.5 and MesP1 overexpressing ES cells. As opposed to MesP1, 15 we did not find a Nkx2.5 driven increase of CD31 expressing cells representing endothelial progenitor cells ( Figure 5D ). This corresponds to the fact that MesP1 demarcates all progenitors of the cardiovascular lineage, [39] [40] [41] [42] [43] whereas Nkx2.5 is primarily expressed in cells contributing to the myocardium. Figure 3 Increased appearance of cardiomyocytes in Nkx2.5 and MesP1 overexpressing ES cells qRT-PCRs for cardiovascular markers at day 10 (panels 1-2) and day 6 (panels 3-8) of differentiation. hMesP1 and EGFP transfected clones served as controls (data are mean + SEM, n ¼ 3).
Divergent effects of Nkx2.5 and Mesp1 overexpression on the action potential parameters of ES cell-derived cardiomyocytes
We next performed single-cell patch clamp analyses to investigate action potential parameters of spontaneously beating cardiomyocytes in Nkx2.5 and MesP1 overexpressing ES cell clones. As established in our previous work, 15 we chose day 6 þ 12 of EB development for these experiments. In general, all cell types described for isolated beating cardiomyocytes obtained from EB development, namely ventricle-like, atrial-like, and SA/AV (pacemaker-like) cells, as well as intermediate cells are present in preparations from Nkx2.5 and MesP1-ES cell clones as well as controls (Supplementary material online, Figure S3A ; Table 1 ). The action potentials generated by the various cell types did not differ significantly between Nkx2.5, MesP1, and control cells with respect to their distinct parameters such as maximal diastolic potential (MDP), diastolic depolarisation rate (DDR), upstroke velocity or AP/plateau duration, or in their reaction to b-adrenergic (Isoprotenerol) and muscarinic (Carbachol) stimulation, supporting the notion of correct cardiomyocyte development (Figure 6A and B; Supplementary material online, Figure S3B and C; Table 1 ). However, we found highly different distributions of the various cell types in Nkx2.5 vs. MesP1 expressing cells.
Only one cell of 24 (4%) of the analysed Nkx2.5 cells could be classified as an early/intermediate cardiomyocyte, whereas in the MesP1-cell population, 57% (16 of 28 cells) was of the intermediate type. The controls were ranking in the middle with 24% of these early/intermediate cells ( Figure 6A , B, E, F; Table 1 ). Even though there are various types of 'early/intermediate type cells', 18 they could all be identified according to their fast, stable DDRs of 30-60 mV/s and short but distinct plateau phases. In addition, as recently described by us, 15 a small I f was present in all intermediate type cells, setting them clearly apart from pacemaker-like cells which have an at least three times higher I f density, and from atrial-or ventricularlike cells from which basically no I f could be recorded (Figure 6C and D; Table 1) .
As opposed to the distribution of these yet undifferentiated intermediate type cells, the near-mature differentiated ventricular cell type was found in 79% (19 of 24) of the analysed Nkx2.5 cells ( Figure 6F ; Table 1 ), whereas in the MesP-cell population only 25% (seven of 28 cells) ( Figure 6F ; Table 1) , and in the control-cell population, 45% (13 of 29) mature ventricular-like cells were found ( Figure 6E ; Table 1 ). These cells could be clearly distinguished from other more differentiated cell types by a combination of the following action potential parameters (Figure 6A , B; Table 1 Table 1 ) and a slowdown of the AP rate, whereas in SA/AV cells an acceleration was observed.
Discussion
Stem cell based cardiac repair will require sufficient yields of cardiac cell types for transplantation and tissue engineering as well as for innovative approaches such as reseeding whole decellularized hearts. 20 Whereas the latter likely requires the earliest cardiovascular precursors to reconstitute the whole myocardium including the vasculature, direct cell transplantation may rather be dependent on specific ventricular cells, e.g. to repair a typical infarction. We here demonstrate that cell type specific 'cardiovascular forward programming' via overexpression of different early cardiovascular transcription factors with the goal to highly enrich the desired cell type is feasible in pluripotent stem cells. In particular, forced expression of Nkx2.5 enhanced cardiogenesis in murine ES (mES) cells reflected by a fivefold increased appearance of beating foci as well as upregulated cardiac mRNA and protein expression. In contrast to the bHLH transcription factor MesP1 no increase of the endothelial lineage within the cardiovasculogenic mesoderm was observed. In detailed patch clamping analyses, the electrophysiological characteristics corresponded to all subtypes of cardiac ES cell differentiation in EBs programmed with Nkx2.5 as well as MesP1. However, the distribution of cardiomyocytic subtypes had distinct characteristics: MesP1 enhanced the appearance of early/intermediate type cardiomyocytes, whereas Nkx2.5 led to preferentially differentiated ventricular cells.
In our experimental setting using Nkx2.5 overexpressing ES cells under LIF administration, we did not find a significant influence on Oct4, Nanog and Rex-1 expression in the undifferentiated colonies ( Figure 1C) . This corresponds to our previous findings for MesP1 overexpression 15 and shows that neither of the two early cardiac factors investigated is alone sufficient to induce cardiac stem cell Table 1 Electrophysiological parameters of (near-)terminally differentiated cardiomyocytes at developmental day 6þ12 Controls ventr.
(n 5 Single cell patch clamp and I f current density analyses at -110 mV activation reveal all cell types described for cardiac ES cell development in Nkx2. differentiation. Therefore, similar to MesP1-based cardiogenesis likewise Nkx2.5 function requires the initial presence of general mesoderm inducing factors. 15, 44 However, a difference between the hierarchic position of the two factors became evident from FACS analyses for Flk-1 (VEGFR-2, KDR), the earliest surface marker for the lateral mesoderm. 16 Thereby, the Flk-1 positive population in MesP1 overexpressing ES cells first did not significantly increase until days 4-6 of differentiation, when lateral and paraxial mesoderm have formed. 15, 17 However, after that time point the enhanced cardiovascular differentiation in MesP1 overexpressing clones was reflected in three-fold larger Flk-1 expressing populations. 15 We concluded that MesP1-based cardiogenesis depends on initial general mesoderm formation. 44 We now included Nkx2.5 in these analyses to further address its function during cardiovascular differentiation in relation to that of MesP1. Thereby, as opposed to MesP1 we did not observe an increased appearance of Flk-1 expressing cells induced via Nkx2.5 overexpression (Figure 2 ). This indicates that Nkx2.5 alone is not sufficient to shift nascent mesoderm towards a cardiovascular fate but rather requires initial cardiovascular induction via MesP1. In fact Nkx2.5 subsequently promotes terminal differentiation of preferentially ventricular cardiomyocytes as evident from our extensive electrophysiological analyses ( Figure 6) . Therefore, our findings confirm that cardiovascular specification is initiated via MesP1 with key differentiation factors such as Nkx2.5 further downstream. 15, 45, 46 Because direct downstream targets for Nkx2.5/Csx have been identified, such as MEF2-C 47 and ANP, 48 we verified the functionality of our overexpression construct in qRTPCRs after LIF withdrawal indeed revealing increases of mRNA levels for these genes (Figure 3) . In addition, ANP mRNA levels are more abundant in ventricles than in atria during embryonic development and the appearance of increased ANP expression in adult ventricles has become Figure S3A . For controls, Nkx2.5-and MesP1-clones, the diastolic depolarisation rates 'DDR' (A) and AP durations (B) did not differ significantly within the same group, i.e. Vent., Atr., SA/AV or Inter. demonstrating correct differentiation. Refer to Table 1 established as a marker for the induction of the embryonic gene program in ventricular hypertrophy. 49 Therefore our findings confirm an increased ventricular differentiation driven via Nkx2.5.
To analyse potential divergent effects of Nkx2.5 vs. MesP1 on second vs. primary heart field induction, we analysed expression of Isl1 and Tbx20 vs. Tbx5, [32] [33] [34] all of which were significantly increased via either of the two factors ( Figure 3) . In addition, analysing epicardial induction we found Tbx18 and Wt1 mRNAs increased 37, 38 ( Figure 3) . For MesP1, these findings are in agreement with its key role to induce the entire cardiovasculogenic population. 15, [39] [40] [41] [42] [43] 45, 46 Likewise, Nkx2.5 is highly expressed in the early cardiogenic cells in both primary and secondary heart fields. 24, 50, 51 Thereby, Nkx2.5 expressing progenitors do also contribute to the proepicardium expressing Wt1 and Tbx18, whereas Nkx2.5 knockout results in abnormal proepicardial development and decreased expression of Wt1 supporting our findings. 38 Interestingly, Tbx2 mRNA levels were reduced in Nkx2.5 cells when compared with controls and increased in MesP1 cells (Figure 3) . Tbx2 suppresses terminal differentiation of chamber myocardial cells as shown for mice and zebrafish. 35, 36 Therefore, the enhanced Nkx2.5-based ventricular differentiation ( Figure 6 ) is reflected in reduced Tbx2 expression.
Nkx2.5 overexpressing clones behaved similar to those described by us for MesP1 overexpression with respect to the rather crude criterion of spontaneous beating: they started to contract earlier and showed more beating areas (Supplementary material online, Figure S2 and Movies). Our findings correspond to subsequent quantitative FACS analyses, which showed two-fold increased a-Actinin positive cells. This marker is expressed in cardiomyocytes as well as skeletal myocytes ( Figure 5A) . Importantly, cells expressing the cardiac specific sarcomeric proteins TnI and cardiac MLC-1 ( Figure 5B and C) were three-to four-fold increased, which shows that cardiogenesis was specifically induced via Nkx2.5 as well as MesP1 overexpression. Therefore, the effects of Nkx2.5 as well as MesP1 clearly exceed previous reports describing an increased yield of ES cell-derived cardiomyocytes by treatment with retinoic acid, 52 Nitric oxide (NO) and by an inducible NO synthase 53 as well as via loss of RBP-J, a downstream element in the Notch pathway. 54 However, as opposed to our previous findings using MesP1 for cardiovascular forward programming, 15 no increase of CD31 expressing cells representing endothelial progenitor cells was induced via Nkx2.5 ( Figure 5D ). This difference between the two transcription factors is in agreement with the knowledge that MesP1 is sufficient to induce the entire cardiovasculogenic cell population. 15, [39] [40] [41] [42] [43] On the other hand, Nkx2.5 is primarily expressed in cells contributing to the myocardium. Likewise, these findings confirm the molecular hierarchy for the early cardiovascular specification highly conserved in chordates initiated via MesP genes with subordinate factors such as Nkx. The specificity of the cardiogenic effects is further reflected in the numbers of cells expressing a-Actinin, expressed in cardiomyocytes as well as skeletal myocytes as a-Actinin positive cells were only two-fold increased ( Figure 5A) .
To ultimately analyse the suitability of our 'cardiac forward programming' approach, we compared the Nkx2.5 and MesP1 derived cardiomyocytes with control cells at an electrophysiological level. We have recently described that MesP1 overexpression does not interfere with the potency to generate all types of functional cells described for isolated beating cardiomyocytes from EBs. 15, 18, 19 The same holds true for preparations from Nkx2.5 cell clones, where likewise ventricle-like, atrial-like, and SA/AV (pacemakerlike) cells as well as intermediate cells are found in our single cell patch clamp analyses (Suppl. Figure S3A ; Table 1 ). Importantly, correct cardiomyocytic development was not impaired as the action potentials and pharmacological responses of the various cell types did not differ significantly between 'programmed' and control cells (Figure 6A , B; Supplementary material online, Figure S3B and C; Table 1 ). These findings are confirmed via normal patterns of sarcomeric markers ( Figure 4A and B) . However, one major finding of our work described here is the quantitative distribution of the cellular subtypes in Nkx2.5 vs. MesP1 programmed cells, which was highly different: MesP1 promoted the appearance of early/intermediate type cardiomyocytes, whereas Nkx2.5 led to over 75% near terminally differentiated ventricular cells ( Figure 6 ; Table 1 ). These findings account for the more robust maintenance of spontaneously beating foci in MesP1 programmed cells (Supplementary material online, Figure S2 ).
Future stem cell based cardiovascular repair faces a number of hurdles to be overcome. Whereas the cardiac differentiation of classical adult stem cells such as bone marrow derived cells is at present highly questionable, recently a number of promising novel pluripotent cell types have been described. These include spermatogonial and parthenogeneic stem cells as well as reprogrammed cells (iPS) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] While these cells are comparable to ES cells regarding their pluripotency, they are devoid of important ethical issues inescapably connected with human ES cells. The novel cell types have recently been shown to differentiate into true cardiomyocytes, 13 but their use in future therapy or disease models in vitro will require an in-depth understanding of molecular mechanisms underlying cardiovascular stem cell differentiation. In this regard, our present work shows proof of principle for cardiovascular subtype-specific programming of pluripotent stem cells towards a cardiovascular fate without impairing their functionality. Therefore, it will be of great interest to transfer this approach to the various types of native or induced pluripotent stem cells from these novel sources 1-11 using various early cardiovascular transcription factors. This may facilitate the achievement of high yields of the desired cardiac cellular subtype as initially shown here for Nkx2.5 and MesP1. It will be of great interest to use these preprogrammed cells for transplantations into infracted myocardium regarding their beneficial effects. Ultimately, this approach may also help to overcome the hurdles yet existing for cardiovascular differentiation of adult multipotent stem cells in their native state.
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